Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GO…

Overview of attention for article published in Annals of Oncology, September 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 3 news stories from 3 outlets.

After a radical hysterectomy and pelvic lymphadenectomy for early-stage cervical cancer, patients often face decisions about…

Grade 3 or 4 AEs were experienced by 42.9% of patients who received cisplatin plus radiation compared with 15.3% of patients…

Adding cisplatin to radiation therapy (RT) did not statistically improve relapse-free survival (RFS) or overall survival (OS…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.